Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Neuromodulation Market, and What Factors Will Drive It?

In the last few years, the neuromodulation market has seen substantial expansion. The market is slated to grow from $6.96 billion in 2024 to $7.62 billion in 2025, representing a compound annual growth rate (CAGR) of 9.5%. Key factors stimulating growth during the historical period include an increase in chronic illnesses, robust clinical evidence and research, patients’ preference for non-invasive treatments, government funding and initiatives, broadening application areas, and strategic collaborations and partnerships.

The size of the neuromodulation market is predicted to experience a significant growth spurt in the coming years, eventually reaching $11.57 billion by 2029 with an 11.0% compound annual growth rate (CAGR). This growth during the forecast period can be credited to the shrinkage of devices, increase in attention towards neurological disorders in the elderly, broader uses in psychiatry, patient-oriented strategies, and the worldwide extension of healthcare availability. Prominent themes during this forecast period encompass the introduction of artificial intelligence (AI), technological advancements, non-invasive methods of neuromodulation, closed-loop neuromodulation systems, wider indications, as well as wireless and wearable neuromodulation devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Neuromodulation Market?

The increase in neurological disorders is anticipated to spur the growth of the neuromodulation market. Neurological disorders are typically known as issues that impact the brain along with the nerves that are spread across the human body, including the spinal cord. Neuromodulation provides the potential to treat and regulate a broad array of neurological disorders and ailments, such as Parkinson’s and Alzheimer’s diseases. For example, in April 2022, the European Brain Council, a Belgium-based coordinating international health organization, recorded over 600 neurological diseases and approximately 300 psychiatric conditions. Globally, 50 million individuals were living with Alzheimer’s and other dementias. Epilepsy, a commonplace disorder, affected 65 million individuals worldwide. Within Europe, 10.5 million people were diagnosed with dementia, a number expected to rise to 18.7 million by 2050. Therefore, the rise in neurological disorders is fuelling the growth of the neuromodulation market.

Which Primary Segments of the Neuromodulation Market Are Driving Growth and Industry Transformations?

The neuromodulationmarket covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Neuromodulation Market?# Market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Neuromodulation Market?

The emergence of new technology is a growing trend in the neuromodulation sector. To retain their market dominance, leading enterprises are creating innovative technological solutions. For instance, in January 2024, digital self-neuromodulation therapy specialist, GrayMatters Health, situated in Israel, introduced a new FDA-approved self-neuromodulation therapy for PTSD branded as Prism. This path-breaking device merges an EEG cap with software, enabling patients to regulate their emotional reactions through neurofeedback. The technology is expected to compliment traditional psychotherapy and pharmacotherapy, providing patients with active symptom management tools. Moreover, in December 2022, Abbott Laboratories, a medical devices and healthcare firm in the US, released the Eterna spinal cord stimulation (SCS) system, known as the smallest rechargeable and implantable spinal cord stimulator. Eterna SCS uses Abbott’s proprietary low-dose BurstDR stimulation, the sole SCS waveform innovation backed by the highest level of clinical evidence (1A evidence), proven to alleviate pain by an additional 23% compared to conventional waveform technology methods.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What Parameters Are Used to Define the Neuromodulation Market?

Neuromodulation is the modification of nerve activity (or modulation) by delivering electrical or pharmacological substances directly to a specific location. It is a reversible procedure performed to relieve pain.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model